data_1zok_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1zok _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.811 0.339 . . . . 0.0 111.156 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' TYR . . . . . . . . . . . . . 9.1 p90 -129.31 141.86 50.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.01 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -141.14 116.97 10.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.033 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -88.67 139.84 30.06 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-O 121.409 0.623 . . . . 0.0 111.006 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' ILE . . . . . . . . . . . . . 2.8 tt -120.49 113.87 41.73 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-N 114.955 -1.02 . . . . 0.0 111.276 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' THR . . . . . 0.432 HG23 HG23 ' A' ' 302' ' ' ILE . 3.0 m -103.36 99.24 9.07 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.591 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 5.7 mt -108.01 160.46 15.77 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-O 121.792 0.806 . . . . 0.0 111.599 -179.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -82.4 161.04 22.63 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 114.297 -1.32 . . . . 0.0 113.294 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' ARG . . . . . 0.576 ' HB2' ' O ' ' A' ' 301' ' ' SER . 3.2 ttt-85 -69.58 167.16 17.44 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 112.84 -1.982 . . . . 0.0 110.932 179.252 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . 0.424 ' CA ' HD22 ' A' ' 234' ' ' LEU . . . -112.81 -113.41 3.21 Favored Glycine 0 N--CA 1.437 -1.29 0 CA-C-N 115.376 -0.829 . . . . 0.0 112.793 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 7.1 p30 179.75 -38.28 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.998 0.428 . . . . 0.0 110.351 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 83.1 p -161.86 31.0 0.12 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.662 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 143.45 84.94 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.959 -0.638 . . . . 0.0 112.401 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . 0.424 HD22 ' CA ' ' A' ' 230' ' ' GLY . 8.4 mt -46.06 -39.59 9.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.697 0.284 . . . . 0.0 111.603 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . 0.41 ' O ' ' HB ' ' A' ' 259' ' ' ILE . . . 136.06 -23.24 3.36 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.376 -0.916 . . . . 0.0 112.681 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' PHE . . . . . 0.428 ' CB ' HG13 ' A' ' 258' ' ' ILE . 32.2 p90 -109.29 146.9 33.53 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.818 0.342 . . . . 0.0 111.287 -179.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' SER . . . . . 0.429 ' OG ' ' CG2' ' A' ' 256' ' ' THR . 1.2 t -110.7 158.88 18.14 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-O 121.436 0.636 . . . . 0.0 110.838 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 2.8 pt -136.45 152.2 29.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 114.979 -1.009 . . . . 0.0 111.479 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -120.53 142.49 49.28 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.557 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -156.18 163.33 31.88 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.588 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -173.49 73.8 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.764 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 4.7 p -89.81 -52.13 5.14 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.815 0.34 . . . . 0.0 110.479 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -154.12 13.52 0.44 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.692 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' ASN . . . . . 0.406 ' HB2' ' HB2' ' A' ' 289' ' ' HIS . 0.9 OUTLIER -95.56 -58.79 0.19 Allowed Pre-proline 0 CA--C 1.53 0.173 0 C-N-CA 121.256 -0.178 . . . . 0.0 111.153 -179.996 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -82.97 -39.29 0.13 Allowed 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.454 2.103 . . . . 0.0 112.319 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' HIS . . . . . . . . . . . . . 21.9 p-80 -163.23 149.83 12.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.742 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -54.82 151.96 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.251 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -175.48 153.94 16.48 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.476 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -88.67 -42.13 12.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.793 0.33 . . . . 0.0 110.979 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -81.69 109.52 16.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.888 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 9.0 t -80.16 -25.75 39.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.163 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 4.4 m -54.29 113.07 1.12 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.918 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -88.72 153.52 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.66 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -116.87 160.0 21.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.506 0.67 . . . . 0.0 112.004 -179.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.446 HG21 HD12 ' A' ' 255' ' ' ILE . 29.2 mt -80.55 149.35 5.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.051 179.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' THR . . . . . 0.429 ' CG2' ' OG ' ' A' ' 237' ' ' SER . 9.9 t -111.3 -48.99 3.04 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -178.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -164.5 150.89 10.84 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 -179.033 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . 0.428 HG13 ' CB ' ' A' ' 236' ' ' PHE . 1.5 mp -106.93 104.42 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.414 178.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' ILE . . . . . 0.41 ' HB ' ' O ' ' A' ' 235' ' ' GLY . 4.8 mt -84.34 116.98 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.119 0 CA-C-O 121.042 0.448 . . . . 0.0 111.44 -178.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 6.8 m -65.97 142.18 57.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.805 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 117.57 32.64 1.43 Allowed Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.515 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -152.84 173.65 31.77 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.379 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -52.32 -38.56 58.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.812 0.339 . . . . 0.0 111.183 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -61.84 -53.74 51.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.02 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -65.76 -34.57 78.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.232 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -62.31 -43.52 98.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.998 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 62.9 t0 -85.09 -27.04 26.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.942 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 157.79 -108.23 0.35 Allowed Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.516 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . 0.422 ' HD3' ' CD2' ' A' ' 236' ' ' PHE . 0.3 OUTLIER 61.99 97.54 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.934 0.397 . . . . 0.0 110.998 179.988 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 43.5 mt -81.67 171.38 14.66 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.907 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.01 106.36 4.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.796 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 272' ' ' VAL . . . . . . . . . . . . . 3.0 t -102.67 159.67 4.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.31 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 11.1 m-20 -151.76 17.98 0.7 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.4 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -137.4 173.81 11.27 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 120.882 0.372 . . . . 0.0 111.423 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 275' ' ' CYS . . . . . . . . . . . . . 4.0 m -79.12 142.2 36.62 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.0 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -77.49 151.81 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.747 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -75.76 -41.98 51.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.687 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 278' ' ' ARG . . . . . . . . . . . . . 3.8 ptm180 -157.1 154.87 30.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.196 0.522 . . . . 0.0 111.036 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 11.6 p -131.07 123.78 54.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.906 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 1.7 t30 58.99 33.52 23.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.771 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 78.65 -2.14 2.36 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.524 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -121.2 138.63 54.13 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.838 0.351 . . . . 0.0 111.104 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -78.33 117.57 19.7 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.246 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 12.6 p -97.38 42.56 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.223 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 285' ' ' ARG . . . . . 0.434 ' O ' ' HD3' ' A' ' 285' ' ' ARG . 0.0 OUTLIER -90.82 4.41 51.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.704 0.764 . . . . 0.0 110.946 179.988 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -119.86 61.54 0.84 Allowed 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.909 -1.042 . . . . 0.0 110.876 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 287' ' ' VAL . . . . . 0.454 ' CG1' ' HB3' ' A' ' 291' ' ' LYS . 0.2 OUTLIER -142.75 176.57 3.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.4 0.619 . . . . 0.0 111.37 -179.936 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 288' ' ' THR . . . . . . . . . . . . . 1.6 p -103.82 -149.96 0.41 Allowed 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 177.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 289' ' ' HIS . . . . . 0.406 ' HB2' ' HB2' ' A' ' 244' ' ' ASN . 3.5 t-160 -88.15 -46.03 9.62 Favored 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 120.43 -0.508 . . . . 0.0 110.066 179.056 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -76.19 -18.08 59.23 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.081 179.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 291' ' ' LYS . . . . . 0.454 ' HB3' ' CG1' ' A' ' 287' ' ' VAL . 0.3 OUTLIER -81.56 -41.26 21.85 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.444 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -61.92 -42.0 98.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.898 179.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 2.6 t -61.27 -36.89 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-O 121.089 0.471 . . . . 0.0 110.669 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 294' ' ' GLU . . . . . 0.436 ' O ' ' HB2' ' A' ' 298' ' ' GLU . 5.6 mm-40 -84.71 -30.36 24.82 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.026 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -57.42 -28.16 63.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.933 0.396 . . . . 0.0 111.431 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -93.1 -55.72 3.23 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.738 0.78 . . . . 0.0 109.914 179.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . 0.461 ' HD2' ' HA ' ' A' ' 297' ' ' LYS . 2.7 tptm -51.69 -45.47 63.51 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.554 -1.203 . . . . 0.0 110.404 179.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 298' ' ' GLU . . . . . 0.436 ' HB2' ' O ' ' A' ' 294' ' ' GLU . 1.2 tm-20 -84.43 6.22 24.21 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.737 -1.12 . . . . 0.0 112.808 -179.225 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -64.44 -26.81 68.61 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.042 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 120.37 -165.25 13.77 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.387 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 301' ' ' SER . . . . . 0.576 ' O ' ' HB2' ' A' ' 229' ' ' ARG . 0.4 OUTLIER -58.5 -87.1 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.858 0.361 . . . . 0.0 110.719 179.968 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 302' ' ' ILE . . . . . 0.432 HG23 HG23 ' A' ' 226' ' ' THR . 0.1 OUTLIER -78.63 130.1 36.64 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.922 0 CA-C-O 120.864 0.364 . . . . 0.0 110.846 -179.819 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 2.5 t -115.18 126.37 72.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.569 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 304' ' ' ARG . . . . . 0.4 ' HA ' ' HA ' ' A' ' 226' ' ' THR . 0.0 OUTLIER -112.24 126.07 54.84 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.971 0.415 . . . . 0.0 111.244 -179.604 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 36.0 mt -115.56 133.66 55.82 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.408 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 306' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -109.97 131.92 54.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.981 0.419 . . . . 0.0 111.069 -179.589 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 16.6 m -137.51 125.87 32.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.806 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 7.0 ttmt -117.96 141.73 48.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.982 0.42 . . . . 0.0 111.024 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 19.6 mtm-85 -132.37 119.83 21.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.849 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 9.8 tpt180 -92.15 139.73 30.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.779 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -95.4 137.1 34.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.875 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . 0.438 ' O ' ' CG ' ' A' ' 313' ' ' PHE . . . -150.45 -172.11 4.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.066 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 313' ' ' PHE . . . . . 0.438 ' CG ' ' O ' ' A' ' 312' ' ' ALA . 47.8 p90 . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.29 -0.862 . . . . 0.0 111.421 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.811 0.339 . . . . 0.0 111.156 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 222' ' ' TYR . . . . . . . . . . . . . 9.1 p90 -129.31 141.86 50.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.01 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -141.14 116.97 10.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.033 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -88.67 139.84 30.06 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-O 121.409 0.623 . . . . 0.0 111.006 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 225' ' ' ILE . . . . . 0.509 HG23 ' O ' ' A' ' 225' ' ' ILE . 2.8 tt -120.49 113.87 41.73 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-N 114.955 -1.02 . . . . 0.0 111.276 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 226' ' ' THR . . . . . 0.733 HG23 HG23 ' A' ' 302' ' ' ILE . 3.0 m -103.36 99.24 9.07 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.591 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.568 HD13 ' HD2' ' A' ' 269' ' ' ARG . 5.7 mt -108.01 160.46 15.77 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-O 121.792 0.806 . . . . 0.0 111.599 -179.147 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -82.4 161.04 22.63 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 114.297 -1.32 . . . . 0.0 113.294 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 229' ' ' ARG . . . . . 0.586 ' HB2' ' O ' ' A' ' 301' ' ' SER . 3.2 ttt-85 -69.58 167.16 17.44 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 112.84 -1.982 . . . . 0.0 110.932 179.252 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . -112.81 -113.41 3.21 Favored Glycine 0 N--CA 1.437 -1.29 0 CA-C-N 115.376 -0.829 . . . . 0.0 112.793 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 7.1 p30 179.75 -38.28 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.998 0.428 . . . . 0.0 110.351 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 83.1 p -161.86 31.0 0.12 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.662 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 143.45 84.94 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.959 -0.638 . . . . 0.0 112.401 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 234' ' ' LEU . . . . . 0.466 HD23 ' HA ' ' A' ' 234' ' ' LEU . 8.4 mt -46.06 -39.59 9.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.697 0.284 . . . . 0.0 111.603 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 136.06 -23.24 3.36 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.376 -0.916 . . . . 0.0 112.681 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 236' ' ' PHE . . . . . 0.438 ' CD2' ' HD3' ' A' ' 269' ' ' ARG . 32.2 p90 -109.29 146.9 33.53 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.818 0.342 . . . . 0.0 111.287 -179.342 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 237' ' ' SER . . . . . 0.429 ' OG ' ' CG2' ' A' ' 256' ' ' THR . 1.2 t -110.7 158.88 18.14 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-O 121.436 0.636 . . . . 0.0 110.838 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 238' ' ' ILE . . . . . 0.68 HD12 HD11 ' A' ' 253' ' ' ILE . 2.8 pt -136.45 152.2 29.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 114.979 -1.009 . . . . 0.0 111.479 -179.453 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -120.53 142.49 49.28 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.557 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 240' ' ' GLY . . . . . 0.404 ' CA ' ' HB ' ' A' ' 253' ' ' ILE . . . -156.18 163.33 31.88 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.588 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -173.49 73.8 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.764 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 242' ' ' THR . . . . . 0.622 HG22 ' HA ' ' A' ' 251' ' ' SER . 4.7 p -89.81 -52.13 5.14 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.815 0.34 . . . . 0.0 110.479 179.529 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -154.12 13.52 0.44 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.692 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 244' ' ' ASN . . . . . 0.45 ' HB2' ' HB2' ' A' ' 289' ' ' HIS . 0.9 OUTLIER -95.56 -58.79 0.19 Allowed Pre-proline 0 CA--C 1.53 0.173 0 C-N-CA 121.256 -0.178 . . . . 0.0 111.153 -179.996 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 245' ' ' PRO . . . . . 0.41 ' HD3' ' HB3' ' A' ' 244' ' ' ASN . 83.6 Cg_endo -82.97 -39.29 0.13 Allowed 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.454 2.103 . . . . 0.0 112.319 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 246' ' ' HIS . . . . . . . . . . . . . 21.9 p-80 -163.23 149.83 12.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.742 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -54.82 151.96 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.251 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -175.48 153.94 16.48 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.476 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -88.67 -42.13 12.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.793 0.33 . . . . 0.0 110.979 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 250' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -81.69 109.52 16.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.888 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 251' ' ' SER . . . . . 0.622 ' HA ' HG22 ' A' ' 242' ' ' THR . 9.0 t -80.16 -25.75 39.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.163 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 4.4 m -54.29 113.07 1.12 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.918 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 253' ' ' ILE . . . . . 0.68 HD11 HD12 ' A' ' 238' ' ' ILE . 0.0 OUTLIER -88.72 153.52 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.66 -179.827 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 254' ' ' PHE . . . . . 0.4 ' N ' HG13 ' A' ' 253' ' ' ILE . 4.7 p90 -116.87 160.0 21.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.506 0.67 . . . . 0.0 112.004 -179.174 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.878 HD12 HG11 ' A' ' 272' ' ' VAL . 29.2 mt -80.55 149.35 5.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.051 179.282 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 256' ' ' THR . . . . . 0.432 HG23 ' N ' ' A' ' 257' ' ' LYS . 9.9 t -111.3 -48.99 3.04 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -178.523 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 257' ' ' LYS . . . . . 0.432 ' N ' HG23 ' A' ' 256' ' ' THR . 0.1 OUTLIER -164.5 150.89 10.84 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 -179.033 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.6 HG22 ' O ' ' A' ' 258' ' ' ILE . 1.5 mp -106.93 104.42 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.414 178.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 259' ' ' ILE . . . . . . . . . . . . . 4.8 mt -84.34 116.98 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.119 0 CA-C-O 121.042 0.448 . . . . 0.0 111.44 -178.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 6.8 m -65.97 142.18 57.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.805 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 117.57 32.64 1.43 Allowed Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.515 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -152.84 173.65 31.77 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.379 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -52.32 -38.56 58.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.812 0.339 . . . . 0.0 111.183 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -61.84 -53.74 51.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.02 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -65.76 -34.57 78.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.232 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -62.31 -43.52 98.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.998 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 62.9 t0 -85.09 -27.04 26.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.942 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 157.79 -108.23 0.35 Allowed Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.516 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 269' ' ' ARG . . . . . 0.568 ' HD2' HD13 ' A' ' 227' ' ' LEU . 0.3 OUTLIER 61.99 97.54 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.934 0.397 . . . . 0.0 110.998 179.988 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 43.5 mt -81.67 171.38 14.66 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.907 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.01 106.36 4.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.796 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 272' ' ' VAL . . . . . 0.878 HG11 HD12 ' A' ' 255' ' ' ILE . 3.0 t -102.67 159.67 4.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.31 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 273' ' ' ASN . . . . . 0.41 ' HA ' ' O ' ' A' ' 255' ' ' ILE . 11.1 m-20 -151.76 17.98 0.7 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.4 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 274' ' ' ASP . . . . . 0.522 ' H ' HG12 ' A' ' 272' ' ' VAL . 3.4 t70 -137.4 173.81 11.27 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 120.882 0.372 . . . . 0.0 111.423 -179.56 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 275' ' ' CYS . . . . . . . . . . . . . 4.0 m -79.12 142.2 36.62 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.0 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 276' ' ' ILE . . . . . 0.585 HD13 HD13 ' A' ' 305' ' ' LEU . 0.7 OUTLIER -77.49 151.81 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.747 179.628 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.555 ' O ' HD12 ' A' ' 277' ' ' LEU . 0.1 OUTLIER -75.76 -41.98 51.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.687 -179.941 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 278' ' ' ARG . . . . . . . . . . . . . 3.8 ptm180 -157.1 154.87 30.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.196 0.522 . . . . 0.0 111.036 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 279' ' ' VAL . . . . . 0.445 ' O ' HG13 ' A' ' 279' ' ' VAL . 11.6 p -131.07 123.78 54.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.906 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 1.7 t30 58.99 33.52 23.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.771 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 78.65 -2.14 2.36 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.524 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -121.2 138.63 54.13 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.838 0.351 . . . . 0.0 111.104 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -78.33 117.57 19.7 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.246 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 284' ' ' VAL . . . . . 0.609 HG22 ' O ' ' A' ' 284' ' ' VAL . 12.6 p -97.38 42.56 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.223 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 285' ' ' ARG . . . . . 0.439 ' HD3' ' O ' ' A' ' 285' ' ' ARG . 0.0 OUTLIER -90.82 4.41 51.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.704 0.764 . . . . 0.0 110.946 179.988 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -119.86 61.54 0.84 Allowed 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.909 -1.042 . . . . 0.0 110.876 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 287' ' ' VAL . . . . . 0.628 HG12 ' CD ' ' A' ' 291' ' ' LYS . 0.2 OUTLIER -142.75 176.57 3.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.4 0.619 . . . . 0.0 111.37 -179.936 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 288' ' ' THR . . . . . 0.429 ' H ' ' HB2' ' A' ' 291' ' ' LYS . 1.6 p -103.82 -149.96 0.41 Allowed 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 177.524 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 289' ' ' HIS . . . . . 0.842 ' O ' HG23 ' A' ' 293' ' ' VAL . 3.5 t-160 -88.15 -46.03 9.62 Favored 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 120.43 -0.508 . . . . 0.0 110.066 179.056 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -76.19 -18.08 59.23 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.081 179.593 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 291' ' ' LYS . . . . . 0.628 ' CD ' HG12 ' A' ' 287' ' ' VAL . 0.3 OUTLIER -81.56 -41.26 21.85 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.444 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 292' ' ' ALA . . . . . 0.52 ' O ' HD23 ' A' ' 296' ' ' LEU . . . -61.92 -42.0 98.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.898 179.24 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 293' ' ' VAL . . . . . 0.842 HG23 ' O ' ' A' ' 289' ' ' HIS . 2.6 t -61.27 -36.89 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-O 121.089 0.471 . . . . 0.0 110.669 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 294' ' ' GLU . . . . . 0.457 ' O ' ' HB2' ' A' ' 298' ' ' GLU . 5.6 mm-40 -84.71 -30.36 24.82 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.026 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -57.42 -28.16 63.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.933 0.396 . . . . 0.0 111.431 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.52 HD23 ' O ' ' A' ' 292' ' ' ALA . 0.4 OUTLIER -93.1 -55.72 3.23 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.738 0.78 . . . . 0.0 109.914 179.334 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 297' ' ' LYS . . . . . 0.474 ' HA ' ' HD2' ' A' ' 297' ' ' LYS . 2.7 tptm -51.69 -45.47 63.51 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.554 -1.203 . . . . 0.0 110.404 179.364 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 298' ' ' GLU . . . . . 0.457 ' HB2' ' O ' ' A' ' 294' ' ' GLU . 1.2 tm-20 -84.43 6.22 24.21 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.737 -1.12 . . . . 0.0 112.808 -179.225 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 299' ' ' ALA . . . . . 0.4 ' HB3' ' O ' ' A' ' 296' ' ' LEU . . . -64.44 -26.81 68.61 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.042 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 120.37 -165.25 13.77 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.387 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 301' ' ' SER . . . . . 0.586 ' O ' ' HB2' ' A' ' 229' ' ' ARG . 0.4 OUTLIER -58.5 -87.1 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.858 0.361 . . . . 0.0 110.719 179.968 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 302' ' ' ILE . . . . . 0.733 HG23 HG23 ' A' ' 226' ' ' THR . 0.1 OUTLIER -78.63 130.1 36.64 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.922 0 CA-C-O 120.864 0.364 . . . . 0.0 110.846 -179.819 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 2.5 t -115.18 126.37 72.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.569 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.24 126.07 54.84 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.971 0.415 . . . . 0.0 111.244 -179.604 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 305' ' ' LEU . . . . . 0.585 HD13 HD13 ' A' ' 276' ' ' ILE . 36.0 mt -115.56 133.66 55.82 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.408 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 306' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -109.97 131.92 54.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.981 0.419 . . . . 0.0 111.069 -179.589 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 16.6 m -137.51 125.87 32.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.806 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 7.0 ttmt -117.96 141.73 48.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.982 0.42 . . . . 0.0 111.024 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 19.6 mtm-85 -132.37 119.83 21.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.849 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 9.8 tpt180 -92.15 139.73 30.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.779 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -95.4 137.1 34.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.875 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 312' ' ' ALA . . . . . 0.438 ' O ' ' CG ' ' A' ' 313' ' ' PHE . . . -150.45 -172.11 4.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.066 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 313' ' ' PHE . . . . . 0.438 ' CG ' ' O ' ' A' ' 312' ' ' ALA . 47.8 p90 . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.29 -0.862 . . . . 0.0 111.421 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.811 0.339 . . . . 0.0 111.156 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' TYR . . . . . . . . . . . . . 9.1 p90 -129.31 141.86 50.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.01 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -141.14 116.97 10.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.033 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -88.67 139.84 30.06 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-O 121.409 0.623 . . . . 0.0 111.006 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' ILE . . . . . 0.509 HG23 ' O ' ' A' ' 225' ' ' ILE . 2.8 tt -120.49 113.87 41.73 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-N 114.955 -1.02 . . . . 0.0 111.276 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' THR . . . . . 0.733 HG23 HG23 ' A' ' 302' ' ' ILE . 3.0 m -103.36 99.24 9.07 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.591 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.568 HD13 ' HD2' ' A' ' 269' ' ' ARG . 5.7 mt -108.01 160.46 15.77 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-O 121.792 0.806 . . . . 0.0 111.599 -179.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -82.4 161.04 22.63 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 114.297 -1.32 . . . . 0.0 113.294 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' ARG . . . . . 0.586 ' HB2' ' O ' ' A' ' 301' ' ' SER . 3.2 ttt-85 -69.58 167.16 17.44 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 112.84 -1.982 . . . . 0.0 110.932 179.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . -112.81 -113.41 3.21 Favored Glycine 0 N--CA 1.437 -1.29 0 CA-C-N 115.376 -0.829 . . . . 0.0 112.793 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 7.1 p30 179.75 -38.28 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.998 0.428 . . . . 0.0 110.351 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 83.1 p -161.86 31.0 0.12 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.662 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 143.45 84.94 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.959 -0.638 . . . . 0.0 112.401 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . 0.466 HD23 ' HA ' ' A' ' 234' ' ' LEU . 8.4 mt -46.06 -39.59 9.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.697 0.284 . . . . 0.0 111.603 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 136.06 -23.24 3.36 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.376 -0.916 . . . . 0.0 112.681 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' PHE . . . . . 0.438 ' CD2' ' HD3' ' A' ' 269' ' ' ARG . 32.2 p90 -109.29 146.9 33.53 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.818 0.342 . . . . 0.0 111.287 -179.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' SER . . . . . 0.429 ' OG ' ' CG2' ' A' ' 256' ' ' THR . 1.2 t -110.7 158.88 18.14 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-O 121.436 0.636 . . . . 0.0 110.838 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' ILE . . . . . 0.68 HD12 HD11 ' A' ' 253' ' ' ILE . 2.8 pt -136.45 152.2 29.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 114.979 -1.009 . . . . 0.0 111.479 -179.453 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -120.53 142.49 49.28 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.557 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . 0.404 ' CA ' ' HB ' ' A' ' 253' ' ' ILE . . . -156.18 163.33 31.88 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.588 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -173.49 73.8 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.764 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' THR . . . . . 0.622 HG22 ' HA ' ' A' ' 251' ' ' SER . 4.7 p -89.81 -52.13 5.14 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.815 0.34 . . . . 0.0 110.479 179.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -154.12 13.52 0.44 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.692 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' ASN . . . . . 0.45 ' HB2' ' HB2' ' A' ' 289' ' ' HIS . 0.9 OUTLIER -95.56 -58.79 0.19 Allowed Pre-proline 0 CA--C 1.53 0.173 0 C-N-CA 121.256 -0.178 . . . . 0.0 111.153 -179.996 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' PRO . . . . . 0.41 ' HD3' ' HB3' ' A' ' 244' ' ' ASN . 83.6 Cg_endo -82.97 -39.29 0.13 Allowed 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.454 2.103 . . . . 0.0 112.319 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' HIS . . . . . . . . . . . . . 21.9 p-80 -163.23 149.83 12.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.742 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -54.82 151.96 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.251 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -175.48 153.94 16.48 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.476 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -88.67 -42.13 12.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.793 0.33 . . . . 0.0 110.979 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -81.69 109.52 16.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.888 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . 0.622 ' HA ' HG22 ' A' ' 242' ' ' THR . 9.0 t -80.16 -25.75 39.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.163 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 4.4 m -54.29 113.07 1.12 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.918 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . 0.68 HD11 HD12 ' A' ' 238' ' ' ILE . 0.0 OUTLIER -88.72 153.52 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.66 -179.827 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' PHE . . . . . 0.4 ' N ' HG13 ' A' ' 253' ' ' ILE . 4.7 p90 -116.87 160.0 21.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.506 0.67 . . . . 0.0 112.004 -179.174 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.878 HD12 HG11 ' A' ' 272' ' ' VAL . 29.2 mt -80.55 149.35 5.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.051 179.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . 0.432 HG23 ' N ' ' A' ' 257' ' ' LYS . 9.9 t -111.3 -48.99 3.04 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -178.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' LYS . . . . . 0.432 ' N ' HG23 ' A' ' 256' ' ' THR . 0.1 OUTLIER -164.5 150.89 10.84 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 -179.033 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.6 HG22 ' O ' ' A' ' 258' ' ' ILE . 1.5 mp -106.93 104.42 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.414 178.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' ILE . . . . . . . . . . . . . 4.8 mt -84.34 116.98 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.119 0 CA-C-O 121.042 0.448 . . . . 0.0 111.44 -178.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 6.8 m -65.97 142.18 57.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.805 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 117.57 32.64 1.43 Allowed Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.515 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -152.84 173.65 31.77 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.379 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -52.32 -38.56 58.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.812 0.339 . . . . 0.0 111.183 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -61.84 -53.74 51.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.02 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -65.76 -34.57 78.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.232 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -62.31 -43.52 98.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.998 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 62.9 t0 -85.09 -27.04 26.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.942 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . 157.79 -108.23 0.35 Allowed Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.516 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . 0.568 ' HD2' HD13 ' A' ' 227' ' ' LEU . 0.3 OUTLIER 61.99 97.54 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.934 0.397 . . . . 0.0 110.998 179.988 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 43.5 mt -81.67 171.38 14.66 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.907 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.01 106.36 4.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.796 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 272' ' ' VAL . . . . . 0.878 HG11 HD12 ' A' ' 255' ' ' ILE . 3.0 t -102.67 159.67 4.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.31 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 273' ' ' ASN . . . . . 0.41 ' HA ' ' O ' ' A' ' 255' ' ' ILE . 11.1 m-20 -151.76 17.98 0.7 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.4 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 274' ' ' ASP . . . . . 0.522 ' H ' HG12 ' A' ' 272' ' ' VAL . 3.4 t70 -137.4 173.81 11.27 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 120.882 0.372 . . . . 0.0 111.423 -179.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 275' ' ' CYS . . . . . . . . . . . . . 4.0 m -79.12 142.2 36.62 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.0 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 276' ' ' ILE . . . . . 0.585 HD13 HD13 ' A' ' 305' ' ' LEU . 0.7 OUTLIER -77.49 151.81 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.747 179.628 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.555 ' O ' HD12 ' A' ' 277' ' ' LEU . 0.1 OUTLIER -75.76 -41.98 51.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.687 -179.941 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 278' ' ' ARG . . . . . . . . . . . . . 3.8 ptm180 -157.1 154.87 30.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.196 0.522 . . . . 0.0 111.036 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 279' ' ' VAL . . . . . 0.445 ' O ' HG13 ' A' ' 279' ' ' VAL . 11.6 p -131.07 123.78 54.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.906 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 1.7 t30 58.99 33.52 23.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.771 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 78.65 -2.14 2.36 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.524 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -121.2 138.63 54.13 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.838 0.351 . . . . 0.0 111.104 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -78.33 117.57 19.7 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.246 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 284' ' ' VAL . . . . . 0.609 HG22 ' O ' ' A' ' 284' ' ' VAL . 12.6 p -97.38 42.56 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.223 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 285' ' ' ARG . . . . . 0.439 ' HD3' ' O ' ' A' ' 285' ' ' ARG . 0.0 OUTLIER -90.82 4.41 51.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.704 0.764 . . . . 0.0 110.946 179.988 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -119.86 61.54 0.84 Allowed 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.909 -1.042 . . . . 0.0 110.876 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 287' ' ' VAL . . . . . 0.628 HG12 ' CD ' ' A' ' 291' ' ' LYS . 0.2 OUTLIER -142.75 176.57 3.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.4 0.619 . . . . 0.0 111.37 -179.936 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 288' ' ' THR . . . . . 0.429 ' H ' ' HB2' ' A' ' 291' ' ' LYS . 1.6 p -103.82 -149.96 0.41 Allowed 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 177.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 289' ' ' HIS . . . . . 0.842 ' O ' HG23 ' A' ' 293' ' ' VAL . 3.5 t-160 -88.15 -46.03 9.62 Favored 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 120.43 -0.508 . . . . 0.0 110.066 179.056 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -76.19 -18.08 59.23 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.081 179.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 291' ' ' LYS . . . . . 0.628 ' CD ' HG12 ' A' ' 287' ' ' VAL . 0.3 OUTLIER -81.56 -41.26 21.85 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.444 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . 0.52 ' O ' HD23 ' A' ' 296' ' ' LEU . . . -61.92 -42.0 98.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.898 179.24 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . 0.842 HG23 ' O ' ' A' ' 289' ' ' HIS . 2.6 t -61.27 -36.89 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-O 121.089 0.471 . . . . 0.0 110.669 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 294' ' ' GLU . . . . . 0.457 ' O ' ' HB2' ' A' ' 298' ' ' GLU . 5.6 mm-40 -84.71 -30.36 24.82 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.026 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -57.42 -28.16 63.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.933 0.396 . . . . 0.0 111.431 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.52 HD23 ' O ' ' A' ' 292' ' ' ALA . 0.4 OUTLIER -93.1 -55.72 3.23 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.738 0.78 . . . . 0.0 109.914 179.334 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . 0.474 ' HA ' ' HD2' ' A' ' 297' ' ' LYS . 2.7 tptm -51.69 -45.47 63.51 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.554 -1.203 . . . . 0.0 110.404 179.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 298' ' ' GLU . . . . . 0.457 ' HB2' ' O ' ' A' ' 294' ' ' GLU . 1.2 tm-20 -84.43 6.22 24.21 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.737 -1.12 . . . . 0.0 112.808 -179.225 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 299' ' ' ALA . . . . . 0.4 ' HB3' ' O ' ' A' ' 296' ' ' LEU . . . -64.44 -26.81 68.61 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.042 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 120.37 -165.25 13.77 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.387 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 301' ' ' SER . . . . . 0.586 ' O ' ' HB2' ' A' ' 229' ' ' ARG . 0.4 OUTLIER -58.5 -87.1 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.858 0.361 . . . . 0.0 110.719 179.968 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 302' ' ' ILE . . . . . 0.733 HG23 HG23 ' A' ' 226' ' ' THR . 0.1 OUTLIER -78.63 130.1 36.64 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.922 0 CA-C-O 120.864 0.364 . . . . 0.0 110.846 -179.819 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 303' ' ' VAL . . . . . . . . . . . . . 2.5 t -115.18 126.37 72.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.569 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.24 126.07 54.84 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.971 0.415 . . . . 0.0 111.244 -179.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 305' ' ' LEU . . . . . 0.585 HD13 HD13 ' A' ' 276' ' ' ILE . 36.0 mt -115.56 133.66 55.82 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.408 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 306' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -109.97 131.92 54.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.981 0.419 . . . . 0.0 111.069 -179.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 16.6 m -137.51 125.87 32.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.806 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 7.0 ttmt -117.96 141.73 48.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.982 0.42 . . . . 0.0 111.024 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 19.6 mtm-85 -132.37 119.83 21.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.849 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 9.8 tpt180 -92.15 139.73 30.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.779 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -95.4 137.1 34.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.875 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . 0.438 ' O ' ' CG ' ' A' ' 313' ' ' PHE . . . -150.45 -172.11 4.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.066 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 313' ' ' PHE . . . . . 0.438 ' CG ' ' O ' ' A' ' 312' ' ' ALA . 47.8 p90 . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.29 -0.862 . . . . 0.0 111.421 -179.971 . . . . . . . . 1 1 . 1 stop_ save_